These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2118959)

  • 1. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins.
    Tramontano A; Chothia C; Lesk AM
    J Mol Biol; 1990 Sep; 215(1):175-82. PubMed ID: 2118959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural patterns at residue positions 9, 18, 67 and 82 in the VH framework regions of human and murine immunoglobulins.
    Saul FA; Poljak RJ
    J Mol Biol; 1993 Mar; 230(1):15-20. PubMed ID: 8450531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural repertoire in VH pseudogenes of immunoglobulins: comparison with human germline genes and human amino acid sequences.
    Vargas-Madrazo E; Almagro JC; Lara-Ochoa F
    J Mol Biol; 1995 Feb; 246(1):74-81. PubMed ID: 7853406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
    J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
    Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
    Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between hypervariable regions, antigen-binding specificity and the three-dimensional structure of antibodies.
    Jaton JC; Riesen W
    Ann Immunol (Paris); 1976; 127(3-4):273-83. PubMed ID: 60900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard conformations for the canonical structures of immunoglobulins.
    Al-Lazikani B; Lesk AM; Chothia C
    J Mol Biol; 1997 Nov; 273(4):927-48. PubMed ID: 9367782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA; Wu TT
    J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural repertoire of the human VH segments.
    Chothia C; Lesk AM; Gherardi E; Tomlinson IM; Walter G; Marks JD; Llewelyn MB; Winter G
    J Mol Biol; 1992 Oct; 227(3):799-817. PubMed ID: 1404389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?
    Decanniere K; Muyldermans S; Wyns L
    J Mol Biol; 2000 Jun; 300(1):83-91. PubMed ID: 10864500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
    J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual joining sites in the H and L chains of an anti-lysozyme antibody.
    Hartman AB; Mallett CP; Sheriff S; Smith-Gill SJ
    J Immunol; 1988 Aug; 141(3):932-6. PubMed ID: 3135317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.